Valuation: Grape King Bio Ltd

Capitalization 18.22B 619M 533M 496M 462M 849M 53.21B 950M 6.01B 2.27B 24.89B 2.32B 2.27B 92.14B P/E ratio 2025 *
13.3x
P/E ratio 2026 * -
Enterprise value 18.22B 619M 533M 496M 462M 849M 53.21B 950M 6.01B 2.27B 24.89B 2.32B 2.27B 92.14B EV / Sales 2025 *
1.69x
EV / Sales 2026 * -
Free-Float
79.68%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.40%
1 week-0.40%
Current month-1.99%
1 month-6.11%
3 months-7.87%
6 months-15.17%
Current year-17.73%
More quotes
1 week 119.5
Extreme 119.5
124.5
1 month 119.5
Extreme 119.5
131
Current year 119.5
Extreme 119.5
152
1 year 119.5
Extreme 119.5
158
3 years 119.5
Extreme 119.5
191
5 years 119.5
Extreme 119.5
191
10 years 119.5
Extreme 119.5
282
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2009-06-18
Director of Finance/CFO - 2013-12-31
Chief Tech/Sci/R&D Officer 74 2023-01-03
Director TitleAgeSince
Director/Board Member - 2021-07-14
Director/Board Member 69 2015-06-25
Director/Board Member - 1997-06-15
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.40%-0.40%-18.00%-5.38% 623M
+5.81%+7.89%+111.65%+592.50% 9.97B
-1.24%-1.87%+4.98%+4.32% 9.33B
-3.97%-1.90%+9.66%+140.09% 7.46B
-2.91%+3.73%-9.62%-6.64% 3.42B
-1.54%+0.96%-12.47%-39.77% 2.75B
-2.01%-3.50%+44.92%-9.32% 1.7B
-0.91%-0.63%+10.67%-1.45% 1.07B
0.00%-1.16%+136.11%+10.39% 1.05B
-4.43%-7.39%-17.58%-59.37% 989M
Average -1.16%+1.94%+26.03%+62.54% 3.84B
Weighted average by Cap. -0.17%+3.07%+35.63%+177.07%
See all sector performances

Financials

2025 *2026 *
Net sales 10.8B 367M 316M 294M 274M 503M 31.54B 563M 3.56B 1.35B 14.75B 1.38B 1.35B 54.6B -
Net income 1.37B 46.39M 39.95M 37.17M 34.64M 63.66M 3.99B 71.2M 450M 170M 1.87B 174M 170M 6.91B -
Net Debt - -
More financial data * Estimated data
Logo Grape King Bio Ltd
Grape King Bio Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of healthcare products and beverages. The company operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The Company operates in Taiwan, mainland China and other markets.
Employees
501
More about the company
Date Price Change Volume
25-07-15 123.00 NT$ -0.40% 70,505
25-07-14 123.50 NT$ -0.40% 63,251
25-07-11 124.00 NT$ +1.22% 86,274
25-07-10 122.50 NT$ 0.00% 277,502
25-07-09 122.50 NT$ -0.81% 174,886

End-of-day quote Taiwan S.E., July 14, 2025

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
123.00TWD
Average target price
188.00TWD
Spread / Average Target
+52.85%
Consensus

Quarterly revenue - Rate of surprise